Alimentiv Inc. is pleased to announce the appointment of Pierre Gaudreault as its Chief Executive Officer, effective January 2024. This announcement follows a comprehensive international CEO search conducted by the Board of Directors.

From 1986 to 2020 we operated as Robarts Clinical Trials and built a strong foundation in the medical research community.  In 2020, we became Alimentiv but retained our commitment to clinical trials, medical imaging, and precision medicine for GI-related ailments.  



Alimentiv Announces Pierre Gaudreault As New Chief Executive Officer

Alimentiv Announces Pierre Gaudreault As New Chief Executive Officer

Company Info

Related People